scholarly journals A perspective of private health care providers in the state of Madhya Pradesh on adopting key strategies of the India hypertension control initiative

2020 ◽  
Vol 22 (8) ◽  
pp. 1321-1327
Author(s):  
Ashish Krishna ◽  
Anupam K. Pathni ◽  
Bhawna Sharma ◽  
Roopa Shivashankar ◽  
Suyesh Shrivastava ◽  
...  
Keyword(s):  
Health Care ◽  
Health Care Providers ◽  
The State ◽  
Madhya Pradesh ◽  
Private Health Care ◽  
Care Providers ◽  
Hypertension Control ◽  
Control Initiative

scholarly journals A PERSPECTIVE OF PRIVATE HEALTH CARE PROVIDERS IN THE STATE OF MADHYA PRADESH ON ADOPTING KEY STRATEGIES OF INDIA HYPERTENSION CONTROL INITIATIVE

2021 ◽  
Vol 39 (Supplement 1) ◽  
pp. e385-e386
Author(s):  
Ashish Krishna ◽  
Anupam Khungar Pathni ◽  
Bhawna Sharma ◽  
Roopa Shivashankar ◽  
Suyesh Shrivastava ◽  
...  
Keyword(s):  
Health Care ◽  
Health Care Providers ◽  
The State ◽  
Madhya Pradesh ◽  
Private Health Care ◽  
Care Providers ◽  
Hypertension Control ◽  
Control Initiative

Which are the Best Information Sources for Identifying Emerging Health Care Technologies?: An International Delphi Survey

1998 ◽  
Vol 14 (4) ◽  
pp. 636-643 ◽  
Author(s):  
Glenn Robert ◽  
John Gabbay ◽  
Andrew Stevens
Keyword(s):  
Health Care ◽  
Health Care Providers ◽  
Delphi Study ◽  
Information Sources ◽  
Medical Engineering ◽  
Private Health Care ◽  
Care Providers ◽  
Medical Journals ◽  
Biotechnology Companies ◽  
Health Care Technologies

AbstractThe purpose of this survey was to assess potential information sources for identifying new health care technologies. A three-round Delphi study was conducted, involving 38 selected experts who suggested and assessed potential sources by applying agreed criteria. Twenty-six potential information sources were considered. Timeliness, time efficiency, and sensitivity were important criteria in determining which were the most important sources. The eight recommended sources were: pharmaceutical journals, pharmaceutical and biotechnology companies, specialist medical journals, key medical journals, medical engineering companies, private health care providers, newsletters and bulletins from other health technology assessment agencies, and groups of expert health professionals. There is a need to use a combination of sources because the most useful sources will vary according to the type of technology under consideration.

MINNESOTA TAKES CONTROVERSIAL STEPS TO REFORM HEALTH CARE

PEDIATRICS ◽  
1994 ◽  
Vol 93 (4) ◽  
pp. 560-560
Author(s):  
J. F. L.
Keyword(s):  
Health Care ◽  
Health Care Providers ◽  
Health Reform ◽  
Income Tax ◽  
The State ◽  
Care Providers ◽  
Practice Parameters ◽  
The Law ◽  
Health Legislation ◽  
Care Costs

When Minnesota legislators last spring passed health legislation that included a tax on health care providers, many physicians thought the state had gone too far. As the state begins to implement the law, however (physicians will begin paying the tax in 1994), those same physicians are realizing that their troubles may have just begun. The tax is only one part of a larger health reform package that promises to change the way Minnesota physicians practice. Under the law, for example, the state will assign physicians to some patients. The law also requires the state to develop practice parameters and controls on technology... Beginning in 1994, physicians will pay a 2% income tax on their gross revenues. The tax, which will not be levied on Medicare or Medicaid services or on physicians employed by managed care providers, will help pay for health insurance for the state's approximately 400,000 uninsured. Many physicians opposed the legislation because it will cut into their pay... And to achieve its goal of reducing health care costs by 10% a year for five years, the state will develop and implement practice parameters in an attempt to avoid ineffective treatment.

scholarly journals Are antiretrovirals prescribed according to the recommended prescribed daily doses in the private healthcare sector in South Africa

2011 ◽  
Vol 16 (1) ◽  
Author(s):  
Norah L. Katende-Kyenda ◽  
Martie Lubbe ◽  
Juan H.P. Serfontein ◽  
Ilse Truter
Keyword(s):  
South Africa ◽  
Health Care ◽  
Health Care Providers ◽  
Health Care Professionals ◽  
Health Care Sector ◽  
Hiv And Aids ◽  
Healthcare Sector ◽  
Private Health Care ◽  
Care Providers ◽  
Increased Risk

Current antiretroviral treatment (ART) guidelines recommend different combinations that have led to major improvements in the management of HIV and AIDS in the developed and developing world. With the rapid approval of many agents, health care providers may not be able to familiarise themselves with them all. This lack of knowledge leads to increased risk of dose- prescribing errors, especially by non-HIV and AIDS specialists. The purpose of this retrospective non-experimental, quantitative drug utilisation study was to evaluate if antiretrovirals (ARVs) are prescribed according to the recommended prescribed daily doses (PDDs) in a section of the private health care sector in South Africa (SA). Analysed ARV prescriptions (49995, 81096 and 88988) for HIV and AIDS patients were claimed from a national medicine claims database for the period 1 January 2005 through to 31 December 2007. ARV prescriptions prescribed by general practitioners (GPs) with PDDs not according to the recommended ARV dosing increased dramatically, from 12.33% in 2005 to 24.26% in 2007. Those prescribed by specialists (SPs) increased from 15.46% in 2005 to 35.20% in 2006 and decreased to 33.16% in 2007. The highest percentage of ARV prescriptions with PDDs not according to recommended ARV dosing guidelines was identified in ARV regimens with lopinavir−ritonavir at a PDD of 1066.4/264 mg and efavirenz at a PDD of 600 mg prescribed to patients in the age group of Group 3 (19 years > age ≤ 45 years). These regimens were mostly prescribed by GPs rather than SPs. There is a need for more education for all health care professionals and/or providers in the private health care sector in SA on recommended ARV doses, to avoid treatment failures, development of resistance, drug-related adverse effects and drug interactions.OpsommingHuidige riglyne vir behandeling met antiretrovirale middels beveel verskillende kombinasies aan wat tot groot verbetering in die beheer van MIV en VIGS in die ontwikkelde en ontwikkelende wêreld gelei het. Met die vinnige goedkeuring van talle nuwe middels kan dit gebeur dat verskaffers van gesondheidsorg nie kan bybly om hulle hiermee op hoogte te hou nie. Hierdie gebrek aan kennis lei tot ‘n hoër risiko vir foute in die voorgeskrewe dosis en veral deur persone wat nie spesialiste in MIV en VIGS is nie. Die doel van hierdie nie-eksperimentele, retrospektiewe, kwantitatiewe studie van die gebruik van geneesmiddels was om te bepaal of antiretrovirale middels in ‘n deel van die privaat gesondheidsorgsektor in Suid-Afrika (SA) volgens die aanbevole voorgeskrewe daaglikse dosisse (VDD) voorgeskryf word. Voorskrifte van antiretrovirale middels (49995, 81096 en 88988) aan pasiënte met MIV en VIGS wat in die periode van 1 Januarie 2005 tot 31 Desember 2007 van ‘n nasionale medisyne databasis geëis is, is ontleed. Voorskrifte van antiretrovirale middels deur algemene praktisyns (APs) met VDDs wat nie volgens die aanbevole dosisse vir antiretrovirale middels was nie, het dramaties van 12.33% in 2005 tot 24.26% in 2007 toegeneem. Die wat deur spesialiste (SPs) voorgeskryf is, het van 15.46% in 2005 tot 35.20% in 2006 toegeneem en in 2007 tot 33.16% gedaal. Die hoogste persentasie van voorskrifte vir antiretrovirale middels met VDDs wat nie volgens die riglyne was nie, was in die regimens met lopinavir−ritonavir met ‘n VDD van 1066.4/264 mg en efavirens met ‘n VDD van 600 mg wat aan pasiënte in die ouderdomsgroep van ouer as 19 tot en met 45 jaar voorgeskryf is. Hierdie regimens is meer deur APs as deur SPs voorgeskryf. Daar is ‘n behoefte aan nog opleiding van alle gesondheidsprofessies en/of voersieners in die privaat gesondheidsorgsektor in SA oor die aanbevole antiretrovirale middel-dosisse om mislukking van behandeling, ontwikkeling van weerstand, nadelige effekte vanweë geneesmiddels en geneesmiddel interaksies te voorkom.

scholarly journals Evaluation of quality of TB control services by private health care providers in Plateau state, Nigeria; 2012

2014 ◽  
Vol 17 ◽  
Author(s):  
Luka Mangveep Ibrahim ◽  
Obinna O Oleribe ◽  
Patrick Nguku ◽  
Gabriel Chukwak Tongwong ◽  
Lakda Gonen Mato ◽  
...  
Keyword(s):  
Health Care ◽  
Health Care Providers ◽  
Private Health Care ◽  
Care Providers ◽  
Tb Control ◽  
Plateau State

The State of Smoking Cessation Practices Among Health Care Providers: Educational Preparation and Motivating Factors Presented

2001 ◽  
Vol 13 (1) ◽  
pp. 9-18 ◽  
Author(s):  
Sherry Neil-Urban ◽  
Kathleen Bradshaw Lasala ◽  
Linda Scott
Keyword(s):  
Health Care ◽  
Smoking Cessation ◽  
Health Care Providers ◽  
The State ◽  
Motivating Factors ◽  
Care Providers ◽  
Educational Preparation

Exploratory Spatial Analysis of Transgender Individuals’ Access to Health Care Providers in the State of Minnesota

2014 ◽  
Vol 15 (3-4) ◽  
pp. 129-135 ◽  
Author(s):  
Lewis A. Raynor ◽  
Kelsey McDonald ◽  
Dylan Flunker
Keyword(s):  
Health Care ◽  
Spatial Analysis ◽  
Health Care Providers ◽  
Access To Health Care ◽  
The State ◽  
Care Providers ◽  
Access To Health

scholarly journals Health care seeking patterns of rifampicin-resistant tuberculosis patients in Harare, Zimbabwe: A prospective cohort study

PLoS ONE ◽  
2021 ◽  
Vol 16 (7) ◽  
pp. e0254204
Author(s):  
Rebecca Tadokera ◽  
Stella Huo ◽  
Grant Theron ◽  
Collins Timire ◽  
Salome Manyau-Makumbirofa ◽  
...  
Keyword(s):  
Health Care ◽  
Effective Treatment ◽  
Health Care Providers ◽  
Private Health Care ◽  
Care Providers ◽  
System Delay ◽  
Health Seeking ◽  
Total Delay ◽  
Resistant Tuberculosis ◽  
Initial Symptoms

Background Delays in seeking and accessing treatment for rifampicin-resistant tuberculosis (RR-TB) and multi-drug resistant (MDR-TB) are major impediments to TB control in high-burden, resource-limited settings. Method We prospectively determined health-seeking behavioural patterns and associations with treatment outcomes and costs among 68 RR-TB patients attending conveniently selected facilities in a decentralised system in Harare, Zimbabwe. Results From initial symptoms to initiation of effective treatment, patients made a median number of three health care visits (IQR 2–4 visits) at a median cost of 13% (IQR 6–31%) of their total annual household income (mean cost, US$410). Cumulatively, RR-TB patients most frequently first visited private facilities, i.e., private pharmacies (30%) and other private health care providers (24%) combined. Median patient delay was 26 days (IQR 14–42 days); median health system delay was 97 days (IQR 30–215 days) and median total delay from symptom onset to initiation of effective treatment was 132 days (IQR 51–287 days). The majority of patients (88%) attributed initial delay in seeking care to “not feeling sick enough.” Total delay, total cost and number of health care visits were not associated with treatment or clinical outcomes, though our study was not adequately powered for these determinations. Conclusions Despite the public availability of rapid molecular TB tests, patients experienced significant delays and high costs in accessing RR-TB treatment. Active case finding, integration of private health care providers and enhanced service delivery may reduce treatment delay and TB associated costs.

Sign in / Sign up

Export Citation Format

Share Document